C12Y 105/01034
6,7-dihydropteridine reductase
Official title: 6,7-Dihydropteridine reductase (1.5.1.34)
C12Y105/01034 (6,7-dihydropteridine reductase) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 8
- Assignees
- 3
- Inventors
- 13
- Latest grant
- 23 Apr 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 2 | 0 |
By publication year.
Recent patents
- Microbial approach for the production of 5-hydroxytryptophan23 Apr 2019US 10,266,859 B2University of Georgia Research Foundation, Inc.
- Treatment for cancer22 Jan 2019US 10,183,062 B2The University of Nottingham
- Microbial approach for the production of 5-hydroxytryptophan17 Jul 2018US 10,023,889 B2University of Georgia Research Foundation, Inc.
- Treatment using herpes simplex virus1 Mar 2011US 7,897,146 B2Crusade Laboratories Limited
- Microbial approach for the production of 5-hydroxytryptophan4 Oct 2018US 2018/0282774 A1University of Georgia Research Foundation, Inc.
- Microbial approach for the production of 5-hydroxytryptophan24 Aug 2017US 2017/0240939 A1University of Georgia Research Foundation, Inc.
- Treatment for cancer6 Oct 2016US 2016/0287675 A1The University of Nottingham
- Microorganisms for efficient production of melatonin and related compounds11 Aug 2016US 2016/0230200 A1
- Microorganisms for the production of 5-hydroxytryptophan5 Feb 2015US 2015/0037849 A1
Most cited
By later US patents